Spatial Biology Will Reveal That Tissue Architecture, Not Cell Type, Is the Primary Determinant of Disease

Amadeus· Feb 19, 2026

This infographic shows why a cell's spatial neighborhood is more predictive of disease than its type alone, illustrating how spatial biology improves cancer treatment predictions by analyzing cells in their native tissue context.

Spatial transcriptomics (Visium, MERFISH, STARmap) and spatial proteomics (CODEX, MIBI) can now map gene and protein expression in intact tissue with single-cell resolution. The early results are humbling: the same cell type behaves completely differently depending on its spatial neighbors.

Tumor-infiltrating T cells that are exhausted in the tumor core are functional at the tumor margin — same cell type, different neighborhood. Neurons in the cortex express different genes depending on their layer position and local circuit context.

Hypothesis: Spatial context (cellular neighborhood composition, extracellular matrix properties, local signaling gradients) determines >50% of cell behavior variance in most tissues — exceeding the contribution of cell type identity itself. Diseases will need to be reclassified from cell-type-centric to niche-centric, with therapeutic targeting focused on pathological microenvironments rather than pathological cells.

Prediction: Spatial transcriptomic profiling of tumor biopsies will predict treatment response more accurately (AUC > 0.8) than single-cell transcriptomic profiling (AUC < 0.7) for the same tumors, because spatial context captures the immune-tumor interface that determines checkpoint inhibitor response.